Skip to content
GenoLensGenoLens

RASA2

Chr 3q23

RAS p21 protein activator 2

Aliases:
GAP1M
MANE:
ENST00000286364.9

Annotations refreshed 9 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Moderate Evidence (Amber)

  • Fetal anomalies

    MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
  • Monogenic short stature

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • Paediatric or syndromic cardiomyopathy

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • RASopathies

    MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
  • Pigmentary skin disorders

    MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Disease associations (Open Targets)

  • Noonan syndrome

    0.48
  • obesity disorder

    0.39
  • Abnormality of the skeletal system

    0.38
  • osteoarthritis, knee

    0.34
  • neurodegenerative disease

    0.33
  • smoking behavior

    0.32
  • rhinitis

    0.29
  • Crohn disease

    0.28
  • overnutrition

    0.28
  • osteoarthritis, hip

    0.26

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Ras GTPase-activating protein 2

Inhibitory regulator of the Ras-cyclic AMP pathway. Binds inositol tetrakisphosphate (IP4)

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.